Assessing the Role of STAT3 in DC Differentiation and Autologous DC Immunotherapy in Mouse Models of GBM

Hikmat Assi(Eastern Michigan University), María G. Castro(University of Michigan)

PLoS ONE

May 7, 2014

10.1371/journal.pone.0096318

Cited by 13

Related Papers

HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression

|PLoS Medicine|2009|366

Mechanisms of Glioma Formation: Iterative Perivascular Glioma Growth and Invasion Leads to Tumor Progression, VEGF-Independent Vascularization, and Resistance to Antiangiogenic Therapy

|Neoplasia|2014|155

Combined Immunostimulation and Conditional Cytotoxic Gene Therapy Provide Long-term Survival in a Large Glioma Model

|Cancer Research|2005|127

G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapy

|Science Advances|2021|90

Plasmacytoid Dendritic Cells in the Tumor Microenvironment: Immune Targets for Glioma Therapeutics

|Neoplasia|2012|62